Literature DB >> 17194835

Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

Farid El'Garch1, Katy Jeannot, Didier Hocquet, Catherine Llanes-Barakat, Patrick Plésiat.   

Abstract

Screening of a Tn5-Hg insertional library (12,000 clones) constructed in wild-type Pseudomonas aeruginosa strain PAO1 identified four genes (namely, galU, nuoG, mexZ, and rplY) whose disruption individually led to increased resistance to aminoglycosides (means of twofold). Inactivation of these genes was associated with (i) impaired outer membrane uptake, (ii) reduced active transport, (iii) increased MexXY-OprM-mediated active efflux, and (iv) alteration of target of aminoglycosides, respectively. In addition, suppression of the gene rplY, which codes for ribosomal protein L25, was found to result in both moderate upregulation of the efflux system MexXY-OprM and hypersusceptibility to beta-lactam antibiotics. Construction of double, triple, and quadruple mutants demonstrated cumulative effects of the different mechanisms on aminoglycoside resistance, with MICs increasing from 16- to 64-fold in the quadruple mutant compared to the wild-type strain PAO1. Altogether, these results illustrate how P. aeruginosa may gradually develop high resistance to these antibiotics via intrinsic (i.e., nonenzymatic) mechanisms, as in cystic fibrosis patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194835      PMCID: PMC1803147          DOI: 10.1128/AAC.00704-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Multidrug efflux pumps: expression patterns and contribution to antibiotic resistance in Pseudomonas aeruginosa biofilms.

Authors:  T R De Kievit; M D Parkins; R J Gillis; R Srikumar; H Ceri; K Poole; B H Iglewski; D G Storey
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  J R Aires; T Köhler; H Nikaido; P Plésiat
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability.

Authors:  S Westbrock-Wadman; D R Sherman; M J Hickey; S N Coulter; Y Q Zhu; P Warrener; L Y Nguyen; R M Shawar; K R Folger; C K Stover
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

4.  The general stress protein Ctc of Bacillus subtilis is a ribosomal protein.

Authors:  Matthias Schmalisch; Ines Langbein; Jörg Stülke
Journal:  J Mol Microbiol Biotechnol       Date:  2002-09

5.  Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen.

Authors:  C K Stover; X Q Pham; A L Erwin; S D Mizoguchi; P Warrener; M J Hickey; F S Brinkman; W O Hufnagle; D J Kowalik; M Lagrou; R L Garber; L Goltry; E Tolentino; S Westbrock-Wadman; Y Yuan; L L Brody; S N Coulter; K R Folger; A Kas; K Larbig; R Lim; K Smith; D Spencer; G K Wong; Z Wu; I T Paulsen; J Reizer; M H Saier; R E Hancock; S Lory; M V Olson
Journal:  Nature       Date:  2000-08-31       Impact factor: 49.962

6.  Genetic analysis of a multiresistant strain of Pseudomonas aeruginosa producing PER-1 beta-lactamase.

Authors:  C Llanes; C Neuwirth; F El Garch; D Hocquet; P Plésiat
Journal:  Clin Microbiol Infect       Date:  2006-03       Impact factor: 8.067

7.  Aminoglycoside-resistance mechanisms for cystic fibrosis Pseudomonas aeruginosa isolates are unchanged by long-term, intermittent, inhaled tobramycin treatment.

Authors:  D L MacLeod; L E Nelson; R M Shawar; B B Lin; L G Lockwood; J E Dirk; G H Miller; J L Burns; R L Garber
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant.

Authors:  Charles R Dean; Joanna B Goldberg
Journal:  FEMS Microbiol Lett       Date:  2002-05-07       Impact factor: 2.742

9.  Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya; N Gotoh; H Tsujimoto; T Nishino
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

10.  Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteins.

Authors:  James T H Jo; Fiona S L Brinkman; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

View more
  49 in total

1.  Novel genetic determinants of low-level aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Kristen N Schurek; Alexandra K Marr; Patrick K Taylor; Irith Wiegand; Lucie Semenec; Bhavjinder K Khaira; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191

Review 2.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

Review 4.  Multidrug resistance in bacteria.

Authors:  Hiroshi Nikaido
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

5.  Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1.

Authors:  Yuko Tsutsumi; Haruyoshi Tomita; Koichi Tanimoto
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

6.  Genomic insights into intrinsic and acquired drug resistance mechanisms in Achromobacter xylosoxidans.

Authors:  Yongfei Hu; Yuying Zhu; Yanan Ma; Fei Liu; Na Lu; Xi Yang; Chunguang Luan; Yong Yi; Baoli Zhu
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

7.  Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.

Authors:  Leonie Greipel; Sebastian Fischer; Jens Klockgether; Marie Dorda; Samira Mielke; Lutz Wiehlmann; Nina Cramer; Burkhard Tümmler
Journal:  Antimicrob Agents Chemother       Date:  2016-10-21       Impact factor: 5.191

8.  Mutational activation of the AmgRS two-component system in aminoglycoside-resistant Pseudomonas aeruginosa.

Authors:  Calvin Ho-Fung Lau; Sebastien Fraud; Marcus Jones; Scott N Peterson; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

9.  Determinants of intrinsic aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Thomas Krahn; Christie Gilmour; Justin Tilak; Sebastien Fraud; Nicholas Kerr; Calvin Ho-Fung Lau; Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

10.  Fmt bypass in Pseudomonas aeruginosa causes induction of MexXY efflux pump expression.

Authors:  Ruth E Caughlan; Shubha Sriram; Denis M Daigle; Angela L Woods; Jennifer Buco; Ron L Peterson; Joann Dzink-Fox; Susan Walker; Charles R Dean
Journal:  Antimicrob Agents Chemother       Date:  2009-09-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.